AMAL LTD. - 506597 - Closure of Trading Window
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, trading window for trading in securities of the Company will remain closed from July 01, 2023 to July 16, 2023 (both days inclusive) on account of Board meeting scheduled on July 14, 2023. AMAL LTD. - 506597 - Board Meeting Intimation for Meeting Of The Board Of Directors And Closure Of Trading Window For Quarter Ended June 30, 2023
AMAL LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/07/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the meeting of the Board of Directors of the Company will be held on Friday, July 14, 2023, inter alia, to consider unaudited standalone and consolidated financial results for the quarter ended on June 30, 2023. Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, trading window for trading in securities of the Company will remain closed from July 01, 2023 to July 16, 2023 (both days inclusive). Kindly acknowledge the receipt and inform the members of the stock exchange. AMAL LTD. - 506597 - Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue Pursuant To Regulations 32 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Reference: Scrip ID - AMAL, Scrip Code - 506597
Pursuant to Regulations 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that there is no deviation or variation in the use of the proceeds, from the objects stated in the letter of offer dated February 18, 2023 for Rights Issue of the Company. A statement of deviations, stating that there is no deviation or variation in the utilization of these proceeds, duly reviewed by the Audit Committee, is attached. Kindly acknowledge the receipt. Thank you, AMAL LTD. - 506597 - Annual Results For The Year Ended March 31, 2023
Pursuant to Regulation 30 & 33(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith: 1. Audited standalone and consolidated financial results for the year ended on March 31, 2023. 2. Auditors' report on standalone and consolidated financial results Further, pursuant to SEBI Circular No. CIR/CFD/CMD/56/2016 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we declare and confirm that the Audit Report is unmodified. The above have been taken on record by the Board of Directors of the Company today at their meeting held from 03:15 pm to 06:45 pm. Kindly acknowledge and take note of the same on your record. AMAL LTD. - 506597 - Board Meeting Outcome for Annual Results For The Year Ended March 31, 2023
Pursuant to Regulation 30 & 33(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith: 1. Audited standalone and consolidated financial results for the year ended on March 31, 2023. 2. Auditors' report on standalone and consolidated financial results Further, pursuant to SEBI Circular No. CIR/CFD/CMD/56/2016 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we declare and confirm that the Audit Report is unmodified. The above have been taken on record by the Board of Directors of the Company today at their meeting held from 03:15 pm to 06:45 pm. Kindly acknowledge and take note of the same on your record. AMAL LTD. - 506597 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we are forwarding herewith Certificate received from Link Intime India Pvt Ltd, Registrar and Share Transfer Agent regarding details of shares dematerialised during the quarter ended on March 31, 2023. AMAL LTD. - 506597 - Investment In Amal Speciality Chemicals Ltd, Wholly-Owned Subsidiary
Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company has today (March 30, 2023) acquired: I. 2,00,00,000 non-cumulative redeemable preference shares at ? 10 each at par and II. 27,19,000 equity shares of ? 10 each with premium of ? 100.34 each (total ?110.34 per shares) aggregating to ? 50 cr (including ? 37 cr from the proceeds of the recently completed rights issue of the Company) of Amal Speciality Chemicals Ltd (ASCL), wholly-owned subsidiary company of the Company. Kindly acknowledge the receipt and inform the members of the stock exchange.